Who is sponsoring NCT04967066?

NCT04967066 is sponsored by Sohag University.

What drugs are being tested in NCT04967066?

Interventions in NCT04967066: Serum Levels of Adipocytokines.

What condition does NCT04967066 study?

NCT04967066 studies Febrile Seizure.

Is NCT04967066 still recruiting?

NCT04967066 is currently completed. Last updated 4 October 2022.

Last reviewed 2022-10-04 · How we verify

NCT04967066

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures

Completed Last updated 4 October 2022

What this trial tests

trial testing Serum Levels of Adipocytokines in Febrile Seizure in 90 participants. Completed in 2 October 2022.

Timeline

23 August 2021

Primary endpoint
23 September 2022

2 October 2022

Quick facts

Lead sponsor	Sohag University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	23 August 2021
Primary completion	23 September 2022
Estimated completion	2 October 2022
Sites	1 location across Egypt

Drugs / interventions tested

Serum Levels of Adipocytokines

Conditions studied

Febrile Seizure — all drugs for Febrile Seizure →

Sponsor

Sohag University

Who can join

Adults 6 Months to 6, any sex, with Febrile Seizure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Febrile seizure (FS) is a common neurological condition in children, affecting 2 - 14% of children. FS is defined as seizures occurring in a child aged from six months to five years that is accompanied by a fever (≥38°C) without central nervous system infection. FS is classified into simple febrile seizure (SFS) and complex febrile seizure (CFS). SFS accounts for 70-75% of FS cases and is characterized by being generalized, duration of less than 15 minutes, occurs once in 24 hours, and no previous neurologic problems. We aim to investigate serum levels of adipocytokines, specifically leptin, adiponectin, and IL-6, in children with FS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04967066 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 4 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04967066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing